Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093543156> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2093543156 abstract "Small RNA molecules are a promising new class of drugs by offering expanded targets not druggable by conventional therapies with high target specificity and low toxicity. However, their clinical use is significantly hindered by the lack of vehicles that deliver the molecules efficiently to target tissues and cells. The bladder is an easily accessible hollow organ and is ideal for local delivery of drugs or molecules such as small RNA. RNA activation (RNAa) is a newly discovered mechanism of gene induction triggered by promoter targeted double-stranded RNA, also known as small activating RNA (saRNA). In this study, we investigate, in an orthotopic bladder cancer model, antitumor effects of a saRNA (dsP21) targeting the promoter of the p21WAF1/CIP1 (p21) gene, a key negative regulator of the cell cycle rarely mutated or deleted in bladder cancer. Introducing dsP21 into bladder cancer cells activated p21 expression with subsequent inhibition of cell proliferation, arrest of the cell cycle and induction of apoptosis accompanied by the activation of caspase 3 and PARP. Chemical modification (2′-Fluoro) and subsequent formulation of dsP21 in lipid nanoparticles (LNPs) retained its RNAa activity with minimal immunostimulatory effect and extended its stability in urine, and when delivered intravesically it could well diffuse into the bladder wall. Delivery of LNP-formulated dsP21 (LNP-dsP21) into mouse bladder with established human bladder cancer significantly inhibited tumor growth and extended animal survival with demonstrated p21 activation in vivo. Of particular significance, LNP-dsP21 treatment caused the regression or disappearance of established tumors in 30% of the treated mice. Our results provide proof-of-principle that targeted activation of p21 can be applied to the treatment of bladder cancer and LNP-formulated small RNA can be successfully delivered to the bladder by intravesical instillation. Further clinical development of RNAa-based intravesical therapy is warranted for the treatment of residual and recurring bladder cancer in humans. Acknowledgement: financial support from the AACR Henry Shepard Bladder Cancer Research Grants (09-60-30-LI). Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-363. doi:1538-7445.AM2012-LB-363" @default.
- W2093543156 created "2016-06-24" @default.
- W2093543156 creator A5002137270 @default.
- W2093543156 creator A5007971365 @default.
- W2093543156 creator A5036422573 @default.
- W2093543156 creator A5050838364 @default.
- W2093543156 creator A5080409747 @default.
- W2093543156 creator A5085203302 @default.
- W2093543156 date "2012-04-15" @default.
- W2093543156 modified "2023-09-27" @default.
- W2093543156 title "Abstract LB-363: Intravesical delivery of lipid nanoparticle formulated p21(Waf1/Cip1) activating dsRNA induces tumor regression and enhances animal survival in a orthotopic bladder cancer model" @default.
- W2093543156 doi "https://doi.org/10.1158/1538-7445.am2012-lb-363" @default.
- W2093543156 hasPublicationYear "2012" @default.
- W2093543156 type Work @default.
- W2093543156 sameAs 2093543156 @default.
- W2093543156 citedByCount "0" @default.
- W2093543156 crossrefType "proceedings-article" @default.
- W2093543156 hasAuthorship W2093543156A5002137270 @default.
- W2093543156 hasAuthorship W2093543156A5007971365 @default.
- W2093543156 hasAuthorship W2093543156A5036422573 @default.
- W2093543156 hasAuthorship W2093543156A5050838364 @default.
- W2093543156 hasAuthorship W2093543156A5080409747 @default.
- W2093543156 hasAuthorship W2093543156A5085203302 @default.
- W2093543156 hasConcept C104317684 @default.
- W2093543156 hasConcept C121608353 @default.
- W2093543156 hasConcept C126322002 @default.
- W2093543156 hasConcept C150903083 @default.
- W2093543156 hasConcept C190232843 @default.
- W2093543156 hasConcept C190283241 @default.
- W2093543156 hasConcept C207001950 @default.
- W2093543156 hasConcept C2780352672 @default.
- W2093543156 hasConcept C29537977 @default.
- W2093543156 hasConcept C502942594 @default.
- W2093543156 hasConcept C55493867 @default.
- W2093543156 hasConcept C67705224 @default.
- W2093543156 hasConcept C71924100 @default.
- W2093543156 hasConcept C86803240 @default.
- W2093543156 hasConceptScore W2093543156C104317684 @default.
- W2093543156 hasConceptScore W2093543156C121608353 @default.
- W2093543156 hasConceptScore W2093543156C126322002 @default.
- W2093543156 hasConceptScore W2093543156C150903083 @default.
- W2093543156 hasConceptScore W2093543156C190232843 @default.
- W2093543156 hasConceptScore W2093543156C190283241 @default.
- W2093543156 hasConceptScore W2093543156C207001950 @default.
- W2093543156 hasConceptScore W2093543156C2780352672 @default.
- W2093543156 hasConceptScore W2093543156C29537977 @default.
- W2093543156 hasConceptScore W2093543156C502942594 @default.
- W2093543156 hasConceptScore W2093543156C55493867 @default.
- W2093543156 hasConceptScore W2093543156C67705224 @default.
- W2093543156 hasConceptScore W2093543156C71924100 @default.
- W2093543156 hasConceptScore W2093543156C86803240 @default.
- W2093543156 hasLocation W20935431561 @default.
- W2093543156 hasOpenAccess W2093543156 @default.
- W2093543156 hasPrimaryLocation W20935431561 @default.
- W2093543156 hasRelatedWork W1496497186 @default.
- W2093543156 hasRelatedWork W2014979543 @default.
- W2093543156 hasRelatedWork W2060653112 @default.
- W2093543156 hasRelatedWork W2066321873 @default.
- W2093543156 hasRelatedWork W2070398775 @default.
- W2093543156 hasRelatedWork W2070925801 @default.
- W2093543156 hasRelatedWork W208783499 @default.
- W2093543156 hasRelatedWork W2129373145 @default.
- W2093543156 hasRelatedWork W2153629484 @default.
- W2093543156 hasRelatedWork W2171760054 @default.
- W2093543156 hasRelatedWork W2253877314 @default.
- W2093543156 hasRelatedWork W2304799196 @default.
- W2093543156 hasRelatedWork W2327842290 @default.
- W2093543156 hasRelatedWork W2399087671 @default.
- W2093543156 hasRelatedWork W2520084831 @default.
- W2093543156 hasRelatedWork W2567683017 @default.
- W2093543156 hasRelatedWork W3048475940 @default.
- W2093543156 hasRelatedWork W3083285942 @default.
- W2093543156 hasRelatedWork W3134766435 @default.
- W2093543156 hasRelatedWork W3156604298 @default.
- W2093543156 isParatext "false" @default.
- W2093543156 isRetracted "false" @default.
- W2093543156 magId "2093543156" @default.
- W2093543156 workType "article" @default.